Bioluminescence imaging to monitor the in vivo distribution of administered mesenchymal stem cells in acute kidney injury.
about
Autologous Cells for Kidney BioengineeringIn vivo bioluminescent imaging (BLI): noninvasive visualization and interrogation of biological processes in living animalsBiodistribution, migration and homing of systemically applied mesenchymal stem/stromal cellsPractical Issues with the Use of Stem Cells for Cancer Gene TherapyTargeting Endogenous Repair Pathways after AKI.Imaging technologies for monitoring the safety, efficacy and mechanisms of action of cell-based regenerative medicine therapies in models of kidney disease.A biological global positioning system: considerations for tracking stem cell behaviors in the whole body.Biodistribution of mesenchymal stem cell-derived extracellular vesicles in a model of acute kidney injury monitored by optical imagingProtective effect and localization by optical imaging of human renal CD133+ progenitor cells in an acute kidney injury modelDirect evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescent imaging.Preparatory studies of composite mesenchymal stem cell islets for application in intraportal islet transplantation.Collecting duct-derived cells display mesenchymal stem cell properties and retain selective in vitro and in vivo epithelial capacity.Serial transplantation and long-term engraftment of intra-arterially delivered clonally derived mesenchymal stem cells to injured bone marrow.Maximum efficacy of mesenchymal stem cells in rat model of renal ischemia-reperfusion injury: renal artery administration with optimal numbersAmniotic Fluid Derived Stem Cells with a Renal Progenitor Phenotype Inhibit Interstitial Fibrosis in Renal Ischemia and Reperfusion Injury in Rats.Marrow Stromal Cell Infusion Rescues Hematopoiesis in Lethally Irradiated Mice despite Rapid Clearance after Infusion.Capturing the stem cell paracrine effect using heparin-presenting nanofibres to treat cardiovascular diseases.Therapeutic effects of intrabone and systemic mesenchymal stem cell cytotherapy on myeloma bone disease and tumor growthEndothelial colony-forming cells ameliorate endothelial dysfunction via secreted factors following ischemia-reperfusion injury.Exogenous MC3T3 preosteoblasts migrate systemically and mitigate the adverse effects of wear particlesRoute of delivery influences biodistribution of human bone marrow-derived mesenchymal stromal cells following experimental bone marrow transplantation.Mesenchymal stem cell-based therapy.A physiologically based kinetic model for elucidating the in vivo distribution of administered mesenchymal stem cells.Mesenchymal stem cell-derived microvesicles protect against acute tubular injury.In Vivo Tracking of Systemically Administered Allogeneic Bone Marrow Mesenchymal Stem Cells in Normal Rats through Bioluminescence Imaging.Survival and function of mesenchymal stem cells (MSCs) depend on glucose to overcome exposure to long-term, severe and continuous hypoxiaImaging mesenchymal stem cell migration and the implications for stem cell-based cancer therapies.Molecular imaging of urogenital diseases.Pathophysiology of acute kidney injuryThe effects of glomerular and tubular renal progenitors and derived extracellular vesicles on recovery from acute kidney injuryEmerging therapeutic approaches for multipotent mesenchymal stromal cells.Strategies for improving the efficacy of bioengineered bone constructs: a perspective.Approaches to the Management of Acute Kidney Injury in Children.Mesenchymal stem cell delivery routes and fate.Angiopoietin-1 treated early endothelial outgrowth cells (eEOCs) are activated in vitro and reduce renal damage in murine acute ischemic kidney injury (iAKI).MSCs: Delivery Routes and Engraftment, Cell-Targeting Strategies, and Immune Modulation.Preischemic Administration of Nonexpanded Adipose Stromal Vascular Fraction Attenuates Acute Renal Ischemia/Reperfusion Injury and Fibrosis.Protective actions of administered mesenchymal stem cells in acute kidney injury: relevance to clinical trials.MRI tracking of transplanted iron-labeled mesenchymal stromal cells in an immune-compromised mouse model of critical limb ischemia.A surgical technique for homogenous renal distribution of substances in rats.
P2860
Q26740036-45F57E23-CFBC-439A-92A9-70C36B1675D5Q27006069-003698BA-CEF7-49B2-9D2C-D8BD98F6DB1FQ28069791-9A6EA549-1249-4207-9C48-4BAA330FF000Q28085238-A7E37FB3-716A-45FB-B873-A3216AADB958Q30278062-1E052159-255A-4363-B1FD-EA0604E4DD67Q30370543-B488BB9E-C088-42F1-A28F-2B3332A7552DQ33541898-D0378117-BE55-4345-BDAD-3A131AFE7724Q33608719-4A9BC754-0D3E-4979-959F-BB8C23797CE6Q33902872-219CF619-EFEF-4BB2-8853-3ADFFDEB74E7Q34162598-BF958CC6-8D6B-4024-BE9D-A66E537A3FFBQ34577332-D95480D6-ADDE-49FD-852C-F40C9734D07AQ34787735-855FB284-4E30-4684-B8BA-65B1BD9B5E6CQ34997877-D4DCB40C-A8BD-4D25-BF72-C3344A95B112Q35122939-3E7A5361-BC51-48BE-A82B-3D23F2DDC347Q35752262-ED0F4A4D-C70D-4ECB-94E7-3138F854E182Q35779505-6689ECC2-77A9-42A1-867B-9CD8F0FB6EB9Q36023234-4654DE75-5188-4B1C-B9F6-939CF8C3FBEBQ36092153-18C945A3-21D1-4690-A7D7-A819BA61C156Q36287886-96A3DCDB-2144-42BB-ABAA-7C50AD7DD15CQ36408124-541BDF39-D433-4E2D-A092-EFBB69E82651Q36506274-F9858293-ECC2-482E-A0F4-9A91F4BC23CAQ36546424-B97481B0-50F2-4F11-B050-38947C5547B4Q36628104-EF40CFA5-DF9E-4452-A22C-2FBEADD78874Q37176871-8104E6F9-A8B3-4E55-A960-7C7435416497Q37218759-6A4BBF15-15C2-416D-94A0-4585667C9EE4Q37295460-8DEFE179-3CB7-4D70-B73B-F1CC1040CB4EQ37298643-360AD62A-F0C4-42E2-B88F-B14E7B04B600Q37550399-D8DE54FB-57D2-4F2F-BF77-4BA3818134A6Q37574787-7D5F96E4-884E-4A68-BCFD-F7918F87B193Q37631034-CEB3D1C8-7B54-46DF-9497-BA448F0D5B74Q37781668-B206638B-DCFE-47D6-A3DF-5E201A541671Q37869382-51CC9617-CC76-4CE1-959A-F660254CCABFQ38094041-912461E8-3E73-4B9F-89EE-C4EA1227F7ABQ38214088-2F790F60-A469-4889-AF35-948513C007A5Q39329102-9DE8B769-1B50-4593-88C8-BD41C75BB6BEQ39356606-FCF2EC1A-58FA-459A-B5F9-6F5333B6183FQ41262142-6F3F51F6-373C-4838-B0B3-652FC5D5C9BFQ42727596-DBA9780A-85CA-4BF3-882C-E1D3CFE4C867Q44074421-EBCA50BE-D287-4EEC-B52C-6EDAFE3AC8A6Q45160226-2D85A201-94D3-4C58-BACF-C72CC9657BCB
P2860
Bioluminescence imaging to monitor the in vivo distribution of administered mesenchymal stem cells in acute kidney injury.
description
2008 nî lūn-bûn
@nan
2008 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Bioluminescence imaging to mon ...... cells in acute kidney injury.
@ast
Bioluminescence imaging to mon ...... cells in acute kidney injury.
@en
type
label
Bioluminescence imaging to mon ...... cells in acute kidney injury.
@ast
Bioluminescence imaging to mon ...... cells in acute kidney injury.
@en
prefLabel
Bioluminescence imaging to mon ...... cells in acute kidney injury.
@ast
Bioluminescence imaging to mon ...... cells in acute kidney injury.
@en
P2093
P2860
P1476
Bioluminescence imaging to mon ...... cells in acute kidney injury.
@en
P2093
Christof Westenfelder
Florian Tögel
Ping Zhang
P2860
P304
P356
10.1152/AJPRENAL.00098.2008
P577
2008-05-14T00:00:00Z